Humana's $560M Surge Boosts Volume Ranking to 216th Despite 2.88% Price Drop

On September 25, 2025, Humana (HUM) traded with a volume of $0.56 billion, marking a 36.92% increase from the previous day’s activity. The stock closed down 2.88%, ranking 216th in trading volume among listed equities.

The decline in HUM’s share price coincided with broader market uncertainty over regulatory developments in healthcare policy. Analysts noted that investor sentiment was dampened by speculative positioning in the sector, as market participants awaited clarity on potential legislative impacts to Medicaid expansion programs. The stock’s performance contrasted with peers in the health insurance space, which saw mixed reactions to the same macroeconomic backdrop.

Trading activity reflected a sharp rise in short-term liquidity, with institutional buyers reportedly reducing exposure to defensive sectors. The volume surge suggests heightened positioning adjustments ahead of upcoming earnings reports from key industry players. However, technical indicators showed bearish momentum, with the 50-day moving average failing to provide support for the stock’s recent price action.

To run this back-test accurately I’ll need a bit more detail: 1. Universe Which market or index should we pull the stocks from? • All listed U.S. equities (NYSE + Nasdaq) • A well-defined subset such as the S&P 500, Russell 3000, or another list you have in mind 2. Holding mechanics Do you want an equal-weighted portfolio that is • Fully rebalanced every day (sell yesterday’s 500 and buy today’s 500), or • A rolling overlap (only replace the names that drop out of the top-500 list)? 3. Trading assumptions Any constraints on slippage, commissions, or overnight holding cost, or can we assume frictionless fills at the next day’s open? Once I have this information I can generate the data-retrieval plan and run the back-test.